PureTech Health
Active
26
33M
13
1.13
4
0.50
4
- Areas of investment
Summary
The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Boston.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the PureTech Health, startups are often financed by InterWest Partners, Wellcome Trust, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are InterWest Partners, Polaris Partners, Wellcome Trust. In the next rounds fund is usually obtained by New Enterprise Associates, InterWest Partners, Prospect Venture Partners.
This organization was formed by Daphne Zohar, John Zabriskie.
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2008. This PureTech Health works on 14 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Vedanta Biosciences, Gelesis, Akili Interactive Labs. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Clinical Trials, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 26
- Lead investments
- 4
- Exits
- 4
- Rounds per year
- 1.13
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (20)
- Health Care (19)
- Medical (9)
- Therapeutics (7)
- Drug Discovery (6) Show 9 more
- Investments by region
-
- United States (26)
- Peak activity year
- 2016
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 16M
- Group Appearance index
- 0.88
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Follica | 12 Aug 2008 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 11M | United States, New Jersey |
| Seaport Therapeutics | 09 Apr 2024 | Early Stage Venture | 100M | United States, Massachusetts, Boston |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.